NEW YORK – A team from Canada and the US has identified frequently-mutated genes and other informative tumor features in nearly 1,500 new and previously profiled cutaneous melanoma cases.
Beyond the potential insights that significantly mutated genes might offer into treatment targets for the disease, the combined data might provide insights into variable treatment outcomes, they reasoned, as well as the overrepresentation of cutaneous melanoma in males, who also tend to have poorer survival after their diagnoses.